Publications (24) Lisandra Muñoz Hidalgo publications

2024

  1. A novel TAp73-inhibitory compound counteracts stemness features of glioblastoma stem cells

    Molecular Oncology

2022

  1. Desmoplastic infantile astrocytoma with atypical phenotype, PTEN homozygous deletion and BRAF V600E mutation

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

  2. Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression

    Cancers, Vol. 14, Núm. 16

2021

  1. The status of egfr modulates the effect of mirna-200c on zeb1 expression and cell migration in glioblastoma cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-18

  2. Whole-exome sequencing, EGFR amplification and infiltration patterns in human glioblastoma

    American journal of cancer research, Vol. 11, Núm. 11, pp. 5543-5558

2020

  1. Currículum oculto

    Claves para la innovación pedagógica ante los nuevos retos: respuestas en la vanguardia de la práctica educativa

  2. Identification of New Genetic Clusters in Glioblastoma Multiforme: EGFR Status and ADD3 Losses Influence Prognosis

    Cells, Vol. 9, Núm. 11

  3. Identification of a Novel BRCA1 Alteration in Recurrent Melanocytoma Resulting in Increased Proliferation

    Journal of neuropathology and experimental neurology, Vol. 79, Núm. 11, pp. 1233-1238

  4. Pam3CSK4, a TLR2 ligand, induces differentiation of glioblastoma stem cells and confers susceptibility to temozolomide

    Investigational New Drugs, Vol. 38, Núm. 2, pp. 299-310

  5. Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma

    Neoplasia (United States), Vol. 22, Núm. 1, pp. 10-21

  6. Utilidad del aula-taller en la Formación Profesional

    Conference proceedings CIVINEDU 2020: 4th International Virtual Conference on Educational Research and Innovation September 23-24, 2020

2019

  1. Autophagy inhibition as a promising therapeutic target for laryngeal cancer

    Carcinogenesis, Vol. 40, Núm. 12, pp. 1525-1534

  2. Characterization of a new glioblastoma cell line, GB-val4, with unusual TP53 mutation

    Human Cell, Vol. 32, Núm. 4, pp. 557-567

  3. Epigenetic changes underlie the aggressiveness of histologically benign meningiomas that recur

    Human Pathology, Vol. 84, pp. 105-114

2018

  1. Study of the activation of TLR receptors in neurospheres from glioblastoma cells in vitro

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii12

2017

  1. Association between epidermal growth factor receptor amplification and ADP-ribosylation factor 1 methylation in human glioblastoma

    Cellular Oncology, Vol. 40, Núm. 4, pp. 389-399

  2. Deletion of 11q in neuroblastomas drives sensitivity to PARP inhibition

    Clinical Cancer Research, Vol. 23, Núm. 22, pp. 6875-6887

  3. Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma

    Current Oncology, Vol. 24, Núm. 3, pp. e244-e250

2016

  1. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis

    Molecular Oncology, Vol. 10, Núm. 7, pp. 1043-1053

2015

  1. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status

    Neuroscience, Vol. 297, pp. 243-251